BridgeMD
New treatment option for HPV Infection
Official title Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
ClinicalTrials.gov ID: NCT07281599
What this study is testing
- What it's testing
- The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- You are 25 years old or older and have an intact cervix.
- You were referred for a colposcopy after an abnormal Pap or HPV screen.
- Your periods come regularly-about every 21-35 days.
- You own a smartphone, have an email address, and can read the Qvin app instructions in English.
- You are willing to sign the consent form (electronically).
You likely can't join if
- You are pregnant or think you might be.
- You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).
- You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.
- You have already joined this study or are in another cervical-screening / HPV study right now.
See the full eligibility criteria
- You are 25 years old or older and have an intact cervix.
- You were referred for a colposcopy after an abnormal Pap or HPV screen.
- Your periods come regularly-about every 21-35 days.
- You own a smartphone, have an email address, and can read the Qvin app instructions in English.
- You are willing to sign the consent form (electronically).
- You agree to use a condom for any vaginal intercourse or shared penetrative toy use from Q-Pad collection until the colposcopy visit if engaging with a new sexual partner during this period.
- You are pregnant or think you might be.
- You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).
- You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.
- You have already joined this study or are in another cervical-screening / HPV study right now.
The study team makes the final eligibility decision.
Where it's taking place
- New Haven, Connecticut, United States
- Minneapolis, Minnesota, United States
- Akron, Ohio, United States
- Salt Lake City, Utah, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Haven, Connecticut, United States; Minneapolis, Minnesota, United States; Akron, Ohio, United States; Salt Lake City, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.